EUROGENTEC, a global supplier of products and services to scientists in the life science research, diagnostic and pharmaceutical markets, announced the launch of its new website at www.eurogentec.com. This new website provides online visitors and customers with dramatic improvements in navigation, appearance and enhanced ordering capabilities and reflects an increasing commitment to scientists working in our core markets. Our customized contract manufacturing programs enable seamless transition from project inception through development, validation, launch and commercialization.
Project leaders for the new website, Dominique Poncelet, Vincent Pirson, Anthony Meunier and Isabelle Body commented:
“This new website incorporates the latest knowledge on website ergonomics, months of customers’ recommendations, feedback and testing. Our goal was to make it easier for customers and online visitors to find what they are looking for and to enable them to get detailed information about our Services, Applications and Products. Some highlights of our new website include the following:
- New homepage: A clean, uncomplicated design gives a quick overview of our latest and most popular products, company promotions, news and easier access to our Services, Applications and Products.
- New navigation: The main navigation page has been designed to make it easier to quickly access different sections of the website. Internal site navigation and the newly designed search engine enable visitors to rapidly find the specific information they seek with fewer clicks.
- Enhanced ordering interface: The fresh, new look and a redesigned cart make the ordering process simple and easy.
The positive feedback we received from our customers on our new website has made this a most rewarding project”.
About EUROGENTEC
Eurogentec, headquartered in Liège, Belgium, is a leading provider of innovative products and services to the Life Science, Diagnostic and Pharmaceutical communities. The company employs over 300 people worldwide, and has distribution networks in over 40 countries. Production facilities are located in Belgium (Liège), USA (San Diego), Japan and Singapore with increasing redundancy in equipment, and harmonization of methods, procedures and Quality Management Systems. The parent company operates a recently expanded cGMP compliant facility for the production of diagnostic & therapeutic oligonucleotides and an authorized facility for cGMP manufacturing of biologics.